{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:40:26Z","timestamp":1783698026104,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtm.2024.101367","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T07:57:18Z","timestamp":1730793438000},"page":"101367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Human iPSC-derived neural stem cells engraft and improve pathophysiology of MPS I mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Caitlin C.","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0209-4963","authenticated-orcid":false,"given":"Shih-Hsin","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Stover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry F.","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin S.","family":"Monuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2024.101367_bib1","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses, 8 Edition","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.omtm.2024.101367_bib2","doi-asserted-by":"crossref","DOI":"10.1017\/S1462399408000550","article-title":"The mucopolysaccharidoses: a success of molecular medicine","volume":"10","author":"Clarke","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.omtm.2024.101367_bib3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa2106596","article-title":"Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome","volume":"385","author":"Gentner","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101367_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2024.101367_bib5","first-page":"7","article-title":"Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction","volume":"22","author":"Whitley","year":"1986","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.omtm.2024.101367_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtm.2024.101367_bib7","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","article-title":"Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future","volume":"25","author":"Taylor","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2024.101367_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2015.06.002","article-title":"Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment","volume":"116","author":"Shapiro","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib9","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s00702-013-1042-9","article-title":"Induced neural stem cells (iNSCs) in neurodegenerative diseases","volume":"120","author":"Hermann","year":"2013","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.omtm.2024.101367_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.965089","article-title":"Delivering gene therapy for mucopolysaccharide diseases","volume":"9","author":"Wood","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtm.2024.101367_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/374367a0","article-title":"Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain","volume":"374","author":"Snyder","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2024.101367_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.stemcr.2015.02.022","article-title":"Ex\u00a0vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model","volume":"4","author":"Griffin","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omtm.2024.101367_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.omtm.2018.06.005","article-title":"Genetically Corrected iPSC-Derived Neural Stem Cell Grafts Deliver Enzyme Replacement to Affect CNS Disease in Sanfilippo B Mice","volume":"10","author":"Clarke","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101367_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.omtm.2022.10.013","article-title":"Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease","volume":"27","author":"Pearse","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101367_bib15","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.1038\/cddis.2013.430","article-title":"Murine neural stem cells model Hunter disease in\u00a0vitro: glial cell-mediated neurodegeneration as a possible mechanism involved","volume":"4","author":"Fusar Poli","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtm.2024.101367_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.113007","article-title":"iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II","volume":"412","author":"Hong","year":"2022","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omtm.2024.101367_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10545-017-0108-5","article-title":"Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II","volume":"41","author":"Rybov\u00e1","year":"2018","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2024.101367_bib18","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3727\/096368910X498944","article-title":"Embryonic stem cell-derived glial precursors as a vehicle for sulfamidase production in the MPS-IIIA mouse brain","volume":"19","author":"Robinson","year":"2010","journal-title":"Cell Transplant."},{"key":"10.1016\/j.omtm.2024.101367_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s10038-020-0744-8","article-title":"Newborn screening of mucopolysaccharidoses: past, present, and future","volume":"65","author":"Arunkumar","year":"2020","journal-title":"J.\u00a0Hum. Genet."},{"key":"10.1016\/j.omtm.2024.101367_bib20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/jnr.23245","article-title":"Process-based expansion and neural differentiation of human pluripotent stem cells for transplantation and disease modeling","volume":"91","author":"Stover","year":"2013","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.omtm.2024.101367_bib21","article-title":"Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells","volume":"6","author":"Yuan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2024.101367_bib22","doi-asserted-by":"crossref","first-page":"13513","DOI":"10.1073\/pnas.2235846100","article-title":"A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors","volume":"100","author":"Rubin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101367_bib23","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1007\/s11033-021-07069-3","article-title":"The significance of the SDF-1\/CXCR4 signaling pathway in the normal development","volume":"49","author":"Sadri","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.omtm.2024.101367_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.68","article-title":"A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I","volume":"2","author":"Mendez","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101367_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030663","article-title":"Cellular Functions of OCT-3\/4 Regulated by Ubiquitination in Proliferating Cells","volume":"12","author":"Baek","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omtm.2024.101367_bib26","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41467-022-29068-z","article-title":"The Oligodendrocyte Transcription Factor 2 OLIG2 regulates transcriptional repression during myelinogenesis in rodents","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101367_bib27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101367_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2024.101367_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","article-title":"Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications","volume":"9","author":"Cerneckis","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.omtm.2024.101367_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bmt.2016.336","article-title":"Cord blood transplantation: rewind to fast forward","volume":"52","author":"Dahlberg","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtm.2024.101367_bib31","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s11481-011-9336-x","article-title":"CXCL12 signaling in the development of the nervous system","volume":"7","author":"Mithal","year":"2012","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.omtm.2024.101367_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3389\/fnins.2017.00590","article-title":"The Role of SDF-1\/CXCR4\/CXCR7 in Neuronal Regeneration after Cerebral Ischemia","volume":"11","author":"Cheng","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.omtm.2024.101367_bib33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fncel.2014.00065","article-title":"CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems","volume":"8","author":"Guyon","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2024.101367_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tins.2012.06.003","article-title":"Chemokine CXCL12 in neurodegenerative diseases: an SOS signal for stem cell-based repair","volume":"35","author":"Li","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.omtm.2024.101367_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/mps4030050","article-title":"A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types","volume":"4","author":"Chen","year":"2021","journal-title":"Methods Protoc."},{"key":"10.1016\/j.omtm.2024.101367_bib36","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omtm.2024.101367_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2006.08.001","article-title":"Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice","volume":"90","author":"Chung","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2021.03.013","article-title":"Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndrome","volume":"133","author":"Kan","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101429","article-title":"The in\u00a0vivo timeline of differentiation of engrafted human neural progenitor cells","volume":"37","author":"Vogel","year":"2019","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.omtm.2024.101367_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10406-x","article-title":"Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Enhances Recovery in an Ischemic Stroke Pig Model","volume":"7","author":"Baker","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2024.101367_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.aat0473","article-title":"Glia as architects of central nervous system formation and function","volume":"362","author":"Allen","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omtm.2024.101367_bib42","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1080\/15548627.2018.1482147","article-title":"Revisiting LAMP1 as a marker for degradative autophagy-lysosomal organelles in the nervous system","volume":"14","author":"Cheng","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.omtm.2024.101367_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2016.116","article-title":"CD68\/macrosialin: not just a histochemical marker","volume":"97","author":"Chistiakov","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.omtm.2024.101367_bib44","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2024.101367_bib45","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1038\/s41467-019-11962-8","article-title":"Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I","volume":"10","author":"Gomez-Ospina","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2024.101367_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101127","article-title":"Sustained long-term disease correction in a murine model of MPSII following stem cell gene therapy","volume":"31","author":"Ellison","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101367_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/hum.2023.002","article-title":"Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral Disease","volume":"35","author":"Mandolfo","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2024.101367_bib48","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.omtm.2019.04.001","article-title":"Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated","volume":"13","author":"Ellison","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101367_bib49","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911185","article-title":"Haematopoietic stem cell gene therapy with IL-1Ra rescues cognitive loss in mucopolysaccharidosis IIIA","volume":"12","author":"Parker","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtm.2024.101367_bib50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/brain\/awx311","article-title":"Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy","volume":"141","author":"Holley","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.omtm.2024.101367_bib51","doi-asserted-by":"crossref","first-page":"36194","DOI":"10.1074\/jbc.M114.599944","article-title":"Heparan sulfate inhibits hematopoietic stem and progenitor cell migration and engraftment in mucopolysaccharidosis I","volume":"289","author":"Watson","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtm.2024.101367_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41409-019-0546-9","article-title":"Cord blood research, banking, and transplantation: achievements, challenges, and perspectives","volume":"55","author":"Mayani","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.omtm.2024.101367_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107905","article-title":"Clinical outcomes and sustained biochemical engraftment following ex-vivo autologous stem cell gene therapy for mucopolysaccharidosis type IIIA","volume":"141","author":"Jones","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib54","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.ymgme.2021.11.323","article-title":"First-in-human phase I\/II clinical trial of hematopoietic stem and progenitor cell gene therapy for Hurler syndrome: Favorable safety profile and extensive metabolic correction","volume":"135","author":"Tucci","year":"2022","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101271","article-title":"Design and validation of a GMP stem cell manufacturing protocol for MPSII hematopoietic stem cell gene therapy","volume":"32","author":"Ellison","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2024.101367_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107988","article-title":"Design of a multi-center randomized active controlled phase 3 clinical trial (HURCULES) evaluating the safety and efficacy of OTL-203 in patients with MPS IH versus standard of care with allogeneic hematopoietic stem cell transplantation","volume":"141","author":"Orchard","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107874","article-title":"CAMPSIITE\u2122 phase I\/II\/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II)","volume":"141","author":"Harmatz","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.108070","article-title":"First in-human, intracisternal dosing of RGX-111, an investigational AAV gene therapy, for a 21-month-old child with mucopolysaccharidosis type I (MPS I): 3.5 year follow-up","volume":"141","author":"Wang","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.107101","article-title":"Interim results of Transpher A, a multicenter, single-dose clinical trial of UX111 gene therapy for Sanfilippo syndrome type A (mucopolysaccharidosis IIIA)","volume":"138","author":"Flanigan","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2024.101367_bib60","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ar.23723","article-title":"Lentiviral Vectors and Adeno-Associated Virus Vectors: Useful Tools for Gene Transfer in Pain Research","volume":"301","author":"Zheng","year":"2018","journal-title":"Anat. Rec."},{"key":"10.1016\/j.omtm.2024.101367_bib61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050124001839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T21:06:43Z","timestamp":1737666403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050124001839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2329050124001839"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101367","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human iPSC-derived neural stem cells engraft and improve pathophysiology of MPS I mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2024.101367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101367"}}